Pittenger & Anderson Inc. increased its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 0.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,614 shares of the financial services provider’s stock after acquiring an additional 115 shares during the period. Pittenger & Anderson Inc.’s holdings in Aflac were worth $8,132,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Aflac by 6.4% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider’s stock worth $524,846,000 after acquiring an additional 281,148 shares during the period. Guinness Asset Management LTD increased its stake in Aflac by 5.2% in the 4th quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock valued at $247,682,000 after buying an additional 118,720 shares during the last quarter. National Pension Service increased its stake in Aflac by 8.9% in the 3rd quarter. National Pension Service now owns 1,662,514 shares of the financial services provider’s stock valued at $185,869,000 after buying an additional 136,238 shares during the last quarter. Assetmark Inc. increased its stake in Aflac by 0.7% in the 3rd quarter. Assetmark Inc. now owns 1,584,552 shares of the financial services provider’s stock valued at $177,153,000 after buying an additional 10,487 shares during the last quarter. Finally, Barclays PLC increased its stake in Aflac by 10.1% in the 3rd quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider’s stock valued at $155,529,000 after buying an additional 127,911 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have issued reports on AFL. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday. Truist Financial lifted their price target on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Wells Fargo & Company lifted their price target on shares of Aflac from $103.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Finally, Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $103.00.
Aflac Stock Performance
Shares of AFL stock opened at $103.46 on Monday. The company has a market capitalization of $57.48 billion, a price-to-earnings ratio of 10.78, a PEG ratio of 2.10 and a beta of 0.99. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a 50-day simple moving average of $104.18 and a 200 day simple moving average of $107.25. Aflac Incorporated has a 52 week low of $78.38 and a 52 week high of $115.50.
Aflac (NYSE:AFL – Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts predict that Aflac Incorporated will post 6.95 earnings per share for the current year.
Aflac Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s payout ratio is currently 20.83%.
Insider Buying and Selling at Aflac
In other news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.90% of the company’s stock.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- Why Are These Companies Considered Blue Chips?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What is a buyback in stocks? A comprehensive guide for investors
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.